Clinical Utility of Azacitidine in the Management of Acute Myeloid Leukemia: Update on Patient Selection and Reported Outcomes

Acute myeloid leukemia (AML) is predominantly a disease of the elderly, and a significant proportion of these patients are not candidates for intensive, curative-intent therapies. Epigenetic dysregulation resulting in abnormal DNA hypermethylation is one of the hallmarks of AML pathogenesis. For the...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno Vanegas, Yenny, Badar, Talha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793740/
https://www.ncbi.nlm.nih.gov/pubmed/36583031
http://dx.doi.org/10.2147/CMAR.S271442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793740/
https://www.ncbi.nlm.nih.gov/pubmed/36583031
http://dx.doi.org/10.2147/CMAR.S271442

Ejemplares similares